Associate Director, Third Party Due Diligence

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.
Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. Global Procurement is a driving force behind Genmab’s strategic transformation – enabling speed, efficiency, and responsible growth. As Genmab continues to expand globally, Procurement plays a crucial role in accelerating time-to-market for new therapies through optimized sourcing strategies, responsible vendor management, and sustainable partnerships.
Our vision is to build a best-in-class, data – driven procurement organization that powers Genmab’s mission to deliver live-changing science and innovative therapies to patients worldwide.
The Associate Director, Third-Party Due Diligence, Risk & ESG will shape and lead Genmab’s approach to vendor risk management and supplier sustainability. This newly created position offers the opportunity to bring consistency, visibility, and efficiency to how we manage third-party risk – balancing strong governance with business agility.
You will lead a small team of two professionals and work closely with Legal, Compliance, Quality, Finance, and IT to ensure a coordinated, future-ready framework. Third Party Due Diligence and Risk Management
Lead and continuously improve global third-party due diligence and risk management practices
Oversee due diligence activities for new and existing suppliers – covering compliance, financial stability, ethics, data privacy, and GxP requirements
Maintain and strengthen vendor risk management practices through proactive review and monitoring
Partner with cross-functional teams to assess and mitigate risks related to data security, compliance, and supply continuity
ESG and Sustainable Procurement
Partner with the Corporate Sustainability team to define metrics and reporting for supplier sustainability performance
Collaborate with Legal, Compliance, Quality, Finance, and IT Security to ensure cohesive and transparent approach to third-party risk
Provide expert guidance to Procurement colleagues on due diligence, ESG, and risk-related topics
Represent Procurement in relevant internal governance forums and reviews
Team Leadership and Development
Lead and develop a small, high – performance team of two professionals, fostering accountability, collaboration, and professional growth
Bachelor’s or Master's degree in a related field
Minimum 6-7 years of experience in procurement, compliance, or vendor risk management, ideally withing biotech or pharmaceutical industry
Experience leading or improving third – party due diligence and risk management processes
You are a generous collaborator who can work in teams with a broad spectrum of backgrounds
You take pride in enabling the best work of others on the team
For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. Genmab is committed to protecting your personal data and privacy. Xnkfpon Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice ( ).
Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.